Literature DB >> 18355544

Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.

Koei Ikeda1, Hiroaki Nomori, Takeshi Mori, Jiichiro Sasaki, Toshiaki Kobayashi.   

Abstract

A novel germline transmission of the epidermal growth factor receptor (EGFR) mutation V843I in a family with multiple members with lung cancer is reported. The proband was a 70-year-old woman with multiple adenocarcinomas who exhibited secondary EGFR mutations, either L858R or L861Q, in the specimens of resected tumors, in addition to a germline EGFR V843I mutation. These observations suggest that the germline EGFR V843I mutation might have altered EGFR signaling in the multicentric development of adenocarcinoma, bronchoalveolar carcinoma, and atypical adenomatous hyperplasia and also might have had a role in the development of lung cancer in multiple members of her family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355544     DOI: 10.1016/j.athoracsur.2007.10.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

Review 1.  Germline mutations predisposing to non-small cell lung cancer.

Authors:  Gerald H Clamon; Aaron D Bossler; Taher Abu Hejleh; Muhammad Furqan
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Authors:  Kenichi Suda; Kenji Tomizawa; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  Int J Clin Oncol       Date:  2011-06-08       Impact factor: 3.402

Review 3.  Molecular testing in lung cancer in the era of precision medicine.

Authors:  Helmut H Popper; Ales Ryska; József Tímár; Wlodzimierz Olszewski
Journal:  Transl Lung Cancer Res       Date:  2014-10

Review 4.  Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.

Authors:  Erin L Stewart; Samuel Zhixing Tan; Geoffrey Liu; Ming-Sound Tsao
Journal:  Transl Lung Cancer Res       Date:  2015-02

Review 5.  Histopathologic and molecular approach to staging of multiple lung nodules.

Authors:  Frank Schneider; Sanja Dacic
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 6.  Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.

Authors:  A F Gazdar
Journal:  Oncogene       Date:  2009-08       Impact factor: 9.867

7.  Screening for germline EGFR T790M mutations through lung cancer genotyping.

Authors:  Geoffrey R Oxnard; Vincent A Miller; Mark E Robson; Christopher G Azzoli; William Pao; Marc Ladanyi; Maria E Arcila
Journal:  J Thorac Oncol       Date:  2012-06       Impact factor: 15.609

8.  Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.

Authors:  J J Wheler; G S Falchook; A M Tsimberidou; D S Hong; A Naing; S A Piha-Paul; S S Chen; S Fu; B Stephen; J Y Fok; F Janku; R Kurzrock
Journal:  Ann Oncol       Date:  2012-11-08       Impact factor: 32.976

Review 9.  Inherited lung cancer syndromes targeting never smokers.

Authors:  Hiromasa Yamamoto; Yasushi Yatabe; Shinichi Toyooka
Journal:  Transl Lung Cancer Res       Date:  2018-08

Review 10.  Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review.

Authors:  Emma-Anne Karlsen; Sam Kahler; Joan Tefay; Shannon R Joseph; Fiona Simpson
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.